Study of robotic throat surgery for early oropharyngeal cancer
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This study looks at how well different robotic surgery approaches work for people with early oropharyngeal squamous cell carcinoma (throat cancer). You may be asked for consent for extra tissue and imaging analysis to help researchers understand patterns related to outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- Your primary cancer is in the oropharynx (tonsils, soft palate, base of tongue, or the side/back throat area).
- Your pathology test confirms squamous cell carcinoma of the oropharynx.
- Your cancer was treated with trans-oral robotic surgery (TORS), with or without additional treatments afterward.
- Your cancer was early stage (T1 or T2).
- Your TORS surgery happened on or before December 31, 2021.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a cancer’s DNA changes over time in people who had head and neck cancer treated with radiation and then need robot-assisted surgery. It may help doctors understand why some cancers come back or persist and how to better plan treatment.
This Phase 2 trial studies a robotic surgery approach for certain HPV-related throat cancers, using HPV blood tests before and after surgery to guide care. If your cancer is HPV-related and your HPV blood test results match the trial targets, you may be able to join and help improve treatment for future patients.
This trial studies using a robot-assisted operation through the mouth to diagnose or treat certain non-cancer (benign) and cancer (malignant) tumors in the head and neck. It may help some people avoid more invasive surgery by using an approach that reaches the throat and voice box area through the mouth.
This trial tests whether giving chemotherapy before robotic surgery works well for certain p16-positive oropharyngeal (throat) cancers. It aims to shrink or control the cancer and allow the surgeon to remove the tumor with clean margins while avoiding cancer spread beyond the neck.
This study looks at virus-related markers and tiny gene regulators (microRNAs) in tumor tissue from people with certain throat cancers caused by human papilloma virus (HPV). It’s observational, meaning it does not change your treatment, but results may help doctors better understand these cancers and how they behave.
This study collects information and tumor tissue to look for genetic changes in oropharyngeal cancer, especially in patients whose cancer has come back. The goal is to better understand the disease and may help future treatment planning.
Hear when a new Cancer Head Neck trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.